Pharma Middle East November 02-04, 2015 Dubai, UAE

Dr. Fathia El Sharkawi has obtained her PhD in biochemistry and molecular biology from Faculty of Pharmacy, Cairo University in 2000. She has completed postdoctoral studies in Germany from Paul Ehrlich institute in 2006 and Institute of virology, Essen University in 2007. She has been working in Faculty of Pharmacy, Helwan University since 2002. She is currently a head of biochemistry and molecular biology department. She is a member of many scientific societies and a reviewer for few international scientific journals. She is a member of editorial board of Austin Journal of molecular and cellular biology, also she is a member of Tempus project (Advanced Training and Life Long Program in Applied Health Science) with Linnaeus University, Sweden. Research interest: in Cancer biomarkers, cancer therapy, hepatocellular carcinoma, gene therapy and genetic variability of different diseases. Dr. Fathia El Sharkawi had previously worked as manager of scientific development in Kahira Pharmaceutical Company (1995-2000) and as Scientific affairs and registration consultant, Sigma Pharmaceutical Company, Egypt (2000-2008).

Biochemistry and Molecular biology

Abdel-Hameed Ibrahim Mohameed Ebid is a Doctor of Philosophy in Pharmaceutical Science.He was awarded Scientific Research Award in Basic Science and Technology, by Helwan University, Cairo, Egypt He was selected by students as the Best Staff Member, Faculty of Pharmacy, Helwan University, Cairo, Egypt for three consecutive years.

Clinical Practice Clinical Pharmacokinetics Bioequivalence Studies Genetic Studies Computer Packages Instructional Materials

Dr. Arun Shirwaikar completed his graduation and post-graduation from Bombay University and doctorate from Mangalore University. He was with Manipal University after which he joined as a founder Dean of College of Pharmacy, Gulf Medical University, Ajman. He has vast teaching and research experience of about 34 years and has several research publications and a patent to his credit. He has guided several post graduate and PhD students. He has attended and presented papers at several conferences. He has also been a chairman and speaker at several conferences. He is on the editorial panel of several scientific journals and is a member of various professional associations.

Microencapsulation, ophthalmics, sustained release, antigen delivery systems, fast dissolving tablets, TDDS and herbal formulations.

Mirza Rafi Baig is a professor at Dubai Pharmacy College.

Clinical Pharmacy Pharmacy Practice

Dr. Matthias Steiert is the co-founder and Chief Scientific Officer of Los Gatos Pharmaceuticals. He has extensive experience with nano-scale systems both for the development of drug delivery systems and diagnostics. He serves also as a consultant for various companies involved in nanotechnology and is co-founder of Afaf Translations LLC, a scientific language service provider. Previously, he held a position as Senior Director of R&D at Matrix Sensors Inc. and prior to that 10 years of senior-level research positions at several biotechnology companies in the fields of nanotechnology, drug development, diagnostics, and blood safety. Earlier in his career, Dr. Steiert was Senior Scientist at GlaxoSmithKline (Italy), a research fellow at the National Institute of Health and Environment (The Netherlands), and a consultant for the World Health Organization in Egypt and the Lebanon. He received his postdoctoral training from the University of California, Berkeley. Dr. Steiert holds a degree in plant physiology from the University of Freiburg (Germany) and obtained his Ph.D. in biochemistry from the University of Basel (Switzerland).

Chemistry and Biology

Sarvendra Kumar is a visiting professor at Tokyo University of Science.

Nanotechnology

Dr. Janak Padia is presently working as a Professor in the Center of Biomolecular Therapeutics (To evaluate and prioritize its project portfolio and to accelerate development of innovative drugs) at University of Maryland, United States. He was Vice President, Drug R&D Services at Pharmaron and managed integrated projects for chemistry, lead optimization, preclinical candidate identification and development, and IND enabling studies for clients. He has over 25 years of industrial experience in cutting edge drug discovery and development experience and has held management positions of increasing responsibility. Prior to Pharmaron, he was also Director of Chemistry and Drug Development at Avalon Pharmaceuticals where he oversaw a range of drug discovery and development programs and participated in the strategic management of the company. He has extensive experience in drug discovery and development processes, technology evaluation and implementation of project management tools to drive the projects to completion. He also has excellent knowledge drug development, formulation development, IND enabling studies, GLP Tox evaluations, GMP drug manufacturing and regulatory affairs. Dr. Padia has also worked for Parke-Davis/Warner-Lambert (now Pfizer), Discovery Partners, and the NCGC-NCATS-NIH in the therapeutic areas of Cancer, Cardiovascular, CNS and antiviral therapeutics. He has led drug discovery and development efforts during his career that resulted in the identification of several development candidates in the cancer and CNS area. He has authored several scientific publications and is also the inventor of many patents. He holds an adjunct position at Georgetown University Medical Center and serves as an advisor for Drug Discovery Program at GUMC and NIDDK/NIH.

Drug development, formulation development, IND enabling studies, GLP Tox evaluations, GMP drug manufacturing and regulatory affairs

Born in India, Sam received his Bachelor of Pharmacy (BPharm) at the College of Pharmaceutical Sciences located in Manipal. He continued his education at Long Island University in Brooklyn, NY where he became a registered and licensed pharmacist in New York State. Sam devotes much of his free time to charitable and local organizations including Gift of Life International, North American Teluga Society, and the local Rotary Club and is a Paul Harris fellow from Rotary International Club. In 2000 through the Maddali Foundation he established the Valley Pharmacy Scholarship awarded to a Roxbury High School Senior. He has been bestowed with numerous additional awards and licenses for his efforts.

Clinical and Hospital Pharmacy.

He guided 27 M. Pharm students, 04 Ph. D students and 02 on going. He attended 20 National and 08 International Conferences. He presented papers in 16 National and 10 International Conference/Symposia He delivered 52 Invited talk’s delivered in India and abroad. He has filed 16 Indian Patents of which 1 is granted. He is the author of 04 National Text Books, 01 International Book, 12 International Reference Books and 15 Chapters in International Books

Nanotechnology, Nanomedicine, NanoPharmaceuticals, Nanobiopharmaceuticals, Nutraceuticals, Cosmeceuticals, Drug Delivery, Regulatory affairs.

- Prof. Ehab Hassan Esmail Award for distinction in Ph.D. thesis. April, 2005 This Award is provided only to outstanding Egyptian researchers. - Grant from science and technology development fund (project ID: 2943). The amount of fund is L.E. 544,200 for two years. - Minia University award for distinct international publications, 2013. Peer Reviewer - European Journal of Medicinal Chemistry(Journal of Impact factor > 3 )Total 18 Completed Reviewer Assignments. - Talanta (Journal of Impact factor > 3 ) Total 27 Completed Reviewer Assignments. - Plos one: (Journal of Impact factor > 3 ) 1 reviewer assignment. - Anticancer agents in medicinal chemistry, 1 reviewer assignment. - Editorial board membership of Texas J. of analytical and pharmaceutical chemistry.

Pharmaceutical Medicinal chemistry ,Non-Steroidal Anti-Inflammatory Drugs,drug design and Synthesis

I have completed my Ph.D in Pharmacokinetics from faculty of pharmacy, University of Karachi, Pakistan. I have 5 years of industrial and 15 plus years of Academic experience. Presently I am working as Associate Professor. I have 30 International and National publication. I supervised 2 Ph.D and 5 M. Phil students. I am working as a Member of Editor board in Natural Products Chemistry & Research Journal and as a Technical Editor in Asian Journal of Medical Sciences. I have reviewed number of articles in and for different journals. I have attended number of seminars and workshops as participant as well as speaker in different conferences

Pharmacokinetics

• Dr. Khairia Youssef is a Professor of Organic Chemistry since 1999. • Dr. Khairia had the Bachelor of Pharmaceutical Sciences, the Master degree and Ph.D. in Organic Chemistry from Faculty of Pharmacy, Cairo University on 1977, 1980 and 1984, respectively. • On 1988, Dr. Khairia was on a special research assignment with Etreby Computer in Los Angeles, California, U.S.A. in order to: 1) Assist in the design of a stand alone Drug Interaction query system 2) Practical study in Computer Application in Pharmacy Field. 3) Practical study in Computer and its role in the educational process. • On 1992, Dr. Khairia was on a Peace Fellowship for Post Doctoral Research which concerns with "Design and Synthesis of Potential Antileukemic and/or Antiviral 2'-Deoxymethylene Nucleosides" at the University of Southern California, Los Angeles, California. U.S.A., under the supervision of Dr. Eric J. Lien, Ph. D. The design of the work is based on QSAR. • Prof. Dr. Youssef is interested in drug design, synthesis and evaluation of certain pharmacologically active compounds. She published 62 papers in national and international journals. Professor Youssef supervised many researchers and teaching assistants. Professor Youssef published more than 60 publications into National and International Journals in the field of Drug Synthesis. The most recent papers were published between years 2007-2014 while Professor Youssef has been worked at FUE. From time of graduation till now Dr. Khairia taught different undergraduate and post-graduate courses. Prof. Youssef had been awarded the Bronze award from King Abdul Aziz city for science and technology for the exclusive research “Synthesis of Curcumin Analogues as Potential Antioxidant, Cancer Chemopreventive Agents” which had been granted by King Abdul Aziz city for science and technology, Project No. AR 19-39. Prof. Youssef had been awarded a certificate from The Marquis Who's who Publications Board as a subject of biographical record in Who's who in Science and Engineering 2008-2009. Inclusion in which is limited to those individuals who have demonstrated outstanding achievement in their own fields of endeavor and who have, thereby, contributed significantly to the betterment of contemporary society. She had been awarded the silver award from King Abdul Aziz city for science and technology for the exclusive research “Novel Modified Estrogens: Synthesis, Binding Affinity to Estrogen Receptor, Biological and Antitumor Activities of various Novel Modified Estrogen” which had been granted by King Abdul Aziz city for science and technology, Project No. AR 24-4. Prof. Youssef had been awarded the FUE Azazi Award for Outstanding Research for the academic year 2012/2013. This reflects well on the important contributions to the scholarly reputation of FUE. Perzigian, Anthony (perzigaj) PERZIGAJ@UCMAIL.UC.EDU Prof. Youssef as an International Conference Organizer had been awarded a Certificate for Participating as Organizer for the 1st FUE International Conference on Pharmaceutical Technologies (1st FUE-ICPT), Feb, 2012.http://icpt.fue.edu.eg/ Also, Prof. Youssef had been awarded a Certificate for Participating as Organizer for 3rd FUE International Conference of Pharmaceutical Sciences (3rd FUE-ICPS), Feb, 9-11, 2015.

Drug design, synthesis and evaluation of certain pharmacologically active compounds

Dr. Maged Amer has been an independent consultant since 2007, serving both, pharmaceutical and medical devices manufacturers and distributors. With over 40 years of experience working for blue chip companies and Middle East companies out of the GCC, Egypt, Belgium and USA, he has extensive knowledge of the industry and its practices around the world. His has formerly worked for companies including Aventis, Pfizer, Janssen and GSK. Dr. Amer's expertise ranges from ideation of product mix through to designing and project managing the building of appropriate production plant for that specific product mix, sourcing all the know-how from product formulation, processes validation, product testing and trial till final product approval and registration of over 600 drugs, finally planning and implementing product launches. Being one of hand full of experts who have directed the complete establishment of Greenfield manufacturing operations from concept through to break-even, he offers one stop all rounded single point of contact to set plans, strategies and manages all third parties.

Pharmaceutical and medical devices

Dr. Tarun Wadhwa had completed his Masters in Pharmacy (Clinical Pharmacy) from Manipal University, Karnataka, India (2007). He worked as a senior research fellow under Indian Council of Medical Research (ICMR), India (2009). He was awarded for his doctoral studies (PhD) in 2014. Currently, he is working as an assistant professor in RAK College of Pharmaceutical Sciences, RAKMHSU, UAE. His area of interest includes Pharmacovigilance, Pharmacoeconomics, Clinical Research, Rational use of drugs, and patient reported outcomes. He has almost 7 years of experience in academics, research (clinical & academic). He has attended many conferences, workshops (including WHO programmes), CMEs, CPEs, Symposium of National & International repute. He has published more than 10 scientific papers in reputed journals. He has also been invited for delivering guest lectures, sessions at National & International conferences & scientific events. He is a member of many scientific associations and serving as an editorial board member of International Journal of Basic and Clinical Pharmacology.

Pharmacovigilance, Pharmacoeconomics, Clinical Research, Rational use of drugs, and patient reported outcomes

Dr. Afouna received his Ph.D. in Pharmaceutics & Pharma. Tech., University of Utah, Salt Lake City, UT, USA & Al-Azhar University, Egypt. He spent up to 3-years as a post-doctoral & research scientist at Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas of Medical Sciences (UAMS), Little Rock, AR, USA. He is a highly motivated scientist (teacher, researcher) with extensive expertise in development and optimization of nanoemulsion, nanosuspension, gel/hydrogel & self-nanoemulsifying transdermal, topical, ocular & oral drug delivery systems. Focusing upon development of effective, safe and stable anti-glaucoma, anti-diabetic, hypolipidimic, and antihypertension drugs with great emphasize upon the effects of absorption promoters and other formulation-related factors, the physicochemical properties and chirality, upon the pharmacokinetics and biopharmaceutics of the drug. Moreover, he has focused upon development of non-clinical methodologies to assessing the topical bio-efficacy of various antiviral agents. Dr. Afouna has outstanding teaching capabilities & research experiences in pharmaceutical sciences, development and management of several valuable scientific research projects. He has orally presented many of his work in various inter/national meetings. Furthermore, he has authored & coauthored numerous recent research articles, review articles and chapters of books and textbooks. He is a co-founder College of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia where he worked as Professor for more than 6-years. Currently, Dr. Afouna is the professor & chairman of department of pharmaceutics & pharmaceutical technology, college of pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt, 2012 – Present.

Skin Research, Ophthalmic Research, Biopharmaceutics/Pharmacokinetics Research And Solid Dosage Forms.

Alireza Behshadfar has completed his doctorate in General Medicine in 1991 from Medicine Faculty of Tehran University, Iran and his MBA in Integrated Information Processes in 2011 from Julius-Maximilians-Universität Würzburg, Germany. He is Chairman of the board in Rahaward Co., a leading medical device supplier, and vice president of Nikan Medical Group, a premier pharmaceutical organization. He has translated Schwartz's Principles of Surgery, Clinical Neurology (Aminoff), and Clinical Gynecologic Endocrinology and Infertility (Speroff) to Persian and has been serving as an editorial board member of Kowsar Corp., a medium open access publisher of more than 72 journals, a COPE member.

Medical Devices, Marketing, Pharma Industry

Mr. Ben Ajepe is a licensed & registered Pharmacist. He started his sales career in Pfizer a multinational Company in 1987. He loves to understand goals and objectives. He has had a 28+year’s career which has reflected continual advancement, a depth of valuable, diversified leadership experience in cost-effective sales and marketing strategies. All his career life has been involved in improving supply chain management of pharmaceutical products in Nigeria and some African countries. He is currently the MD/CEO of Today’s Pharmacy and Stores Ltd and B.Perazim Pharmaceuticals Ltd.

Sales and Marketing of Pharmaceuticals

Dr. Yousef Alomi, Head of General Administration of Pharmaceutical Care Administration, and Head of National Drug Information Center, MOH Saudi Arabia Dr. Alomi is a product of King Saud University confirmed with the degree of Bachelor of Pharmaceutical Sciences in the year 1992. After six-years of higher study, he earned his Master of Clinical Pharmacy from the same university in the 1998. He is an affiliated clinical instructor of Purdue University in the USA. He is adjunct assistant professor of King Saud University college of Pharmacy. Dr. Alomi was a member of Pharmacy Board at Saudi commission for health Specialties for 1998-2002 and 2008-2012 and Head of Pharmacy Accreditation committee in 2010-2012. He was team member of establishing 1st Pharmacy Residency Program in Saudi Arabia . In the year 2005 he obtained Board Certification of Pharmacotherapy Specialist (BCPS). In the year 2008, he obtained his diploma in business administration from American University in Egypt in 2007, and he obtained a Board Certification of Nutrition Support Pharmacy (BCNSP) in 2009. Dr. Alomi worked as clinical pharmacist in critical care area and nutrition support. He is He is establish and implement several programs at MOH Hospitals at first time; Clinical Pharmacy Program, Medication Safety Program, Pain Management Program, Anticoagulation Program and Pharmacy Infection Control, including 30 Adult and 20 Pediatrics Clinical Pharmacy Program; he founder of Mass Gathering Pharmaceutical Care in Saudi Arabia He became a member of advisory board of the Arab Pharmaceutical Journal in 2010. He became as Pharmacy Board Member of Saudi Commission of Health Care Specialities2010-2013. He had several research in clinical Pharmacy and Pharmacy practice published in ACCP and ISPOR conferences, He had several presentations in the clinical pharmacy and pharmacy practice at several conference in and outside Saudi Arabia.

clinical pharmacy, pharmacy practice

 Ph.D. Clinical Pharmacology, College of Medicine, Mansoura, University, Egypt. 1989 Thesis Title: Influence of oral calcium channel blockers on plasma level of insulin and cortisol (Experimental study).  M.D Thesis in pediatrics 1988 College of Medicine, Cairo University.  M.Sc. in Clinical Pharmacology, College of Medicine, Mansoura University, Egypt 1985. First part (one-year medicine). Second part (one-year pharmacology). Thesis Title: comparative study of the adverse effect of Oxamniquine and Astiban (experimental study).  M.Sc. Pediatric, College of Medicine, Cairo, 1983 (very good).  M.B.Bch., College of Medicine, Cairo University, 1977 (very good with honor).  Diploma in herbal therapy of endocrine and liver diseases with Chinese herbal medicine (2004).  Diploma in herbal therapy of diabetes with Chinese herbal medicine (2002).

 Clinical Pharmacology  Pediatric Pharmacology

• Professor of Microbiology, High Institute of Public Health Alexandria University • Current position: Head of Microbiology& Immunology Department, Faculty of Pharmacy & Drug Manufacturing, Pharos University in Alexandria (2010- up till now) • Head of Microbiology Department, High Institute of Public health, University of Alexandria, (2005 –2008) • Reviewer of the Bulletin of High Institute of Public Health (Bull HIPH), the Journal of the Egyptian Public Health Association, and Journal of the Medical Research Institute. • Supervised a number of research projects, master and doctor theses in different fields of microbiology

Pharmaceutical Microbiology, Infectious diseases, Infection Control, and Sanitary Microbiology.

Educational Background Pharm.D: Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. Ph.D. in Medicinal Chemistry: Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan / Iran & Welsh School of Pharmacy, Cradiff University.U.K. Academic rank: Professor Work Address Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Teaching Experiences: Organic and Medicinal Chemistry, Pharmaceutical Analysis. Membership Membership of Iranian Association of Pharmaceutical Specialist, Tehran Iran. Membership of Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Academic Positions 1999-2001, 2009-2011, 2013 to present: Head of Medicinal Chemistry Department in Pharmacy School at Shiraz University of Medical Sciences. 1999- 2005: Head of Library in Pharmacy School at Shiraz University of Medical Sciences. 2007-2011: Vice-chancellor for Student and Cultural Affairs in Pharmacy School at Shiraz University of Medical Sciences.

Synthesis of clotrimazole analogues (imidazole, triazole, benzimidazole, benztriazole, oxazole and thiazole derivatives) as antifungal agents. Design and synthesis of erlotinib analogues as anticancer agents. Design and synthesis of squalamine analogues and DHFR inhibitors as antileishmania and antiprotozoa agents. Effects of ionic liquids on rate of chemical reactions in synthesis of antifungal agents.

- Distinguished Researcher in Medical Sciences fields for the year 2004. Award of Ministry of Hihger Education and Scientific Research. - Award of Honor, Soka University – Tokyo,Japan - Member of the Steering Committee of the Jordanian Food and Drug Administration (Ministry of Health) (JFDA) - Member of the Steering Committee of the Accreditted Board of the Universities - Member of the Trustees Board of Amman Private University (2002- present ). - Editor-in-Chief of " Jordan Journal of Pharmaceutical Sciences". An International peer-reviewed Journal

- Isolation and structure elucidation of Naturally Occurring Compounds - Evaluation of the active natural products for their biological and pharmacological activities - Formulation of the active natural products in their suitable dosage form

Prof. Dr. Salwa Elmeligie has completed her PhD at the age of 29 years from Cairo University and postdoctoral studies from Faculty of Pharmacy, Iowa University, USA. She is Head of Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University. She is also reviewer for Higher Education Institutions (HEIs), conducted by the National Authority of Quality Assurance and Accreditation of Education (NAQAAE), and credited trainer in Egypt. She has published more than 36 papers in reputed journals and has been serving as an editorial board member of repute in addition to attending more than 20 training courses in Quality Assurance systems.

Synthetic medicinal chemistry: synthesis and characterization of heterocyclic compounds of biological significance in the fields of antihypertensive, anticancer, antimicrobial, etc. This is for international research using modern techniques in synthesis and studying pharmaceutical organic compounds including green chemistry techniques, various chromatographic separation methods, drug design with drug modeling and interpretation of instrumental data, including mass spectrometry, IR, 1HNMR and 13 C NMR spectroscopy.

Dr. Tawfik Mustafa Alhussainy has completed his Ph.D at the age of 32 years from State university of New York at Buffalo and postdoctoral studies from Roswell Park memorial institute at Buffalo, New York. He is the chairman of department of Pharmacology and Biomedical Sciences at many Iraqi and Jordanian universities, a pharmaceutical consulting scientist for drug bioequivalence center (royal scientific society-Amman), and pharmaceutical consultant of Deem-Pharma (GXPs and licensing professionals).He has published more than 21 papers in reputed journals and serving as an editorial board member of development in pharmaceutics.

Bioavailability and Bioequivalence

ADMINISTRATIVE ACTIVITIES • Dean of Faculty of Pharmacy University of Jordan, Amman, Jordan 2014-until now • Dean of Faculty of Rehabilitation Sciences University of Jordan, Amman, Jordan 2013-2014 • Chairman of Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy, University of Jordan, Amman, Jordan 2003-2005. 2012-2013 • Assistant Dean , Faculty of Pharmacy, University of Jordan 1995- 1996 • Chairman of the scientific committee Faculty of Pharmacy, University of Jordan 1996- 1997/2009-2010 • Member of Department Council 1992-2010 • Member of Faculty Council . • Member of Postgraduate Committee. • Member of Department Council. • Member of Faculty Council . • Member of Postgraduate Committee .

1. Antibiotics and the effects of formulation ingredients on antimicrobial activity. 2. Antimicrobial effects (including antifungal, nematicidal etc.) of different plant extracts. 3. The preserving effect of different formulations. 4. Invertebrate pathology. 5. Parasitology. 6. Microbial Resistance and how to improve the effects of antimicrobial agents on resistant strains of microorganisms. 7. Control of cross infections. 8. Disinfection and Sterilization. 9. Nematicidal effects of natural products. 10. Investigation of new anticancer drugs from medicinal local plants. 11. Discovery of new insecticidal natural products from local plants.

Dean of College of Clinical Pharmacy, Member of the scientific council in North Border University.

Anti-inflammatory, Analgesic and Antipyretic Activity,Antibiotics,Antiepileptic Drugs,Pharmaceutical Education,Pharmaco-therapeutics,Anticancer activity

Professor Mohammad Saeid Hejazi has completed his PharmD from Tabriz University of Medical Sciences and awarded a scholarship to study PhD. He obtained his MSc and PhD from King’s College London in 2003 and after coming back to Iran established some laboratories and took part in establishment of some courses locally and nationwide including leading establishment of Pharmaceutical Biotechnology department in Faculty of Pharmacy and Molecular Medicine in School of Advanced Biomedical Sciences in Tabriz University of Medical Sciences. He is the head of Pharmaceutical Biotechnology and Molecular Medicine departments. He is involved in teaching at undergraduate and postgraduate courses and has supervised more than 50 MSc, PharmD and PhD thesis. He has published more than 56 papers including discovery of two new bacterial genus and species.

Pharmaceutical Biotechnology

Dr. Gina Samy El-Feky, earned her Ph.D. in Pharmaceutics from the Faculty of Pharmacy, Cairo Univeristy. She works as an Associate Professor of Pharmaceutics, Pharmaceutical Technology Department, National Research Center and was seconded as Head of the Pharmaceutics Department and Pharmacy Program Leader, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA) since 2011. Dr. Gina works as an expert coordinator of the Ethics and Safety committee of the Faculty of Pharmacy, MSA. Active member of the National Accreditation Committee, Faculty of Pharmacy, MSA University. Member of the founding and organizing committee of MSA Children's University, first Children University in Egypt and Middle East. Selected stakeholder of the African Network for Drugs and Diagnostics Innovations (ANDI), a WHO affiliation in 2009. Member of the Technology Innovation and Commercialization Office, MSA University. Member of the American Association of Pharmaceutical Sciences (AAPS). Member of Society of women in science in developing countries-Egypt. Member of the Egyptian Young Academy of Science. Winner of Best Ph.D. thesis award in Pharmaceutical Sciences, from the National Research Center, 2008. Also, winner of the Scientific Excellence award from the National Research Center, 2011. Research interest is in the field of drug delivery and formulation with a special focus on applications of nanotechnology in drug delivery. Shared as a team member in 6 national research projects and as a co-principal investigator in a research project granted by the science and technology development fund, all in the field of drug delivery. Editorial board member and reviewer for a number of peer reviewed international journals as the Journal of American Association of Pharmaceutical Scientists, International Journal of Pharmacy and Pharmaceutical Sciences, Journal of inclusion phenomena,..etc. Speaker and poster presenter in over 15 national and international conferences. Published 12 peer reviewed in the field of drug delivery and formulation in reputable international journals. Supervised a number of undergraduate research projects, MSc. and Ph.D theses.

Pharmaceutical Drug Delivery.

Atef Abdel-Monem Abdel-Hafez is a professor at Assiut University.

• Design, synthesis of novel medium-sized Macrolides. • Biotransformation of bioactive compounds by using human intestinal bacteria. • Bio-activation of naturally isolated compounds by using human intestinal bacteria. • Isolation and structural elucidation of naturally bioactive compounds. • Chemical and biochemical modifications of lead compounds to maximize the biological activity and reduce toxicity. • Design and synthesis of organic compounds of potential biological activities. • Prodrugs and chemical delivery systems

Vice Dean for Community Service and Environmental Development, Faculty of Pharmacy, Cairo University. Prof. Dr. M. El-Nabarawi becomes assistant editor of Current trends in Biotechnology and Pharmacy Journal. Prof. Dr. M. El-Nabarawi collaborates with University of the Pacific, Stockton, California, USA.

1- Design, development and characterization of advanced drug delivery systems for Oral, Buccal, and Transdermal drug delivery systems. 2- Solubility of drugs in polymer matrices, enhancement of solubility and dissolution.

Member of the Board, KBC Pharmaceutical Company, Tehran, Iran Head, Dept. of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shaheed Beheshti Univ. of Medical Sciences, Tehran, Iran Chairman of the Board, Darou-Pakhsh Pharmaceutical Manufacturing Company, Tehran, Iran.

Pharmacological and Toxicological Screening of synthetic and natural products Drug Utilization Review (DUR) studies of Narcotics and Antiinfectives Epidemiological studies of Opioid use and abuse Jugular vein and carotid artery catheterization in rats and rabbits Metabolic aspects of selenium toxicity Analytical techniques using radioimmunoassay Analysis of mediators of glucoregulation Development of an anesthetic procedure for rabbits (5-hour anesthesia) Assessment of neurochemical and behavioral changes in the CNS Brain microdialysis in rats Analysis of neurotransmitters in CNS using HPLC-ECD Applications of softwares (both IBM and Macintosh) in health sciences

Papapetropoulos Andreas is a professor at National and Kapodistrian University of Athens.

1.Cell signalling 2.Cardiovascular Pharmacology 3.Preclinical drug screening and development 4.Vascular biology

- Elected dean of the College on 2/11/2011 for a period of 3 years. - A member of the Appeals Committee and the Patent Office oppositions - Academy of Scientific Research . - Member of the Committee on drug pricing at the Ministry of Health. - Member of the Committee on upgrades junior faculty and professors in Pharmacognosy and Phytochemistry at the Supreme Council Universities. - Member of the Committee on upgrades junior faculty and professors in pharmacology at Al-Azhar University, 2011. - Member of the Equalization theses of the Supreme Council of Universities. - Member of the Equalization bachelor's degree in pharmacy at the Ministry of Health in Egypt. - Member of the Supreme Council for the sector Universities. - Member of the emanating-up inspection of the Sector Committee on the regulation of private Universities.

• Isolation and structural elucidation of different natural compounds from their natural sources (medicinal plants &marine organisms). • Drug discovery: Anti-tumor, Anti-platelet aggregations, Anti-inflammatory agents, anti-diabetic, molluscicidal and hepatoprotective agents from natural products. • Analysis and standardization of herbal drugs(LC-MS, GC-MS & NMR). • Teaching Medicinal Plants, Pharmacognosy, Phytochemistry, Quality Control for Herbal Medicine for undergraduate students , Biosynthesis of Natural Products as well as Structural Elucidation for postgraduate students • Sophisticated techniques for isolation of natural products (marine &plants). • Botanical studies on medicinal aromatic l plants.

1. Authored a book chapter in Separation Sciences Hand Book on HPTLC published by Elsevier in 2014 2. Editorial Board member American Journal of Modern Chromatography Published by Columbia International Pubishers, Montana, USA 3. Reviewer for several International Journals like Talenta, Acta Chromatographica, Chromatographia, Journal of Planner Chromatography, American Journal of Science & Technology, Journal of AOAC International, Journal of Arabian Universities of Basic and Applied Sciences etc. 4. Member of Research Advisory Board, USA 5. Member Board of Studies in Pharmacy, Faculty of Pharm. Sciences, Bharati Vidyapeeth Deemed University, Pune. 6. Member, Faculty of Pharm. Sciences, Bharati Vidyapeeth Deemed University, Pune. 7. Member, Academic Council, Bharati Vidyapeeth Deemed University, Pune. 8. Inspector, Pharmacy Council of India, New Delhi. 9. Inspector, All India Council for Technical Education, New Delhi.

a) Medicinal Chemistry: Synthesis, Pharmacokinetic and Pharmacological Studies of Prodrugs. b) Pharmaceutical Analysis: Development and Validation of Analytical Methods, Stress Degradation Studies and Stability indicating Analytical methods, Impurity Profiling, Standardization of herbal pharmaceuticals, Pharmacokinetics, Bioanalytical method development and validation.

Dr. Hassan is a Research Assistant Professor in the Department of Pharmaceutical Sciences. He received his B. Pharm degree (Summa Cum Laude) from Faculty of Pharmacy, Helwan University, Cairo, Egypt. Then he joined the School of Pharmacy, University of Maryland where he received his doctorate degree and his post-doctoral training. Dr. Hassan has more than 12 years of experience in conducting pre-clinical and clinical pharmacokinetic studies. He received several national and international awards including the American Association of Pharmaceutical Scientists (AAPS) award in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism/Clinical Sciences (PPDM/CS), Dr. Ralph Shangrow award, Dr. Arthur Shwartz award and the Egyptian Government General Mission award. In 2004, he was inducted as a Rho Chi Honor Society Member and he currently has a joint appointment as an Associate Professor of Pharmaceutics in Faculty of Pharmacy, Helwan University, Egypt. Dr. Hassan is passionate about his research program and he takes pride of being an active registered pharmacist by the American National Association of Boards of Pharmacy (nabp).

Pharmacokinetics, Pharmacodynamics, and Drug Metabolism/Clinical Sciences,Drug development and drug therapy optimization